Daily Stock List
Wind River Energy Corp. (WVR.V)
We are highlighting Wind River Energy Corp. (WVR.V), here at the QualityStocks Daily Newsletter.
Wind River Energy Corp. is a natural gas and oil acquisition and development company. The Company is focusing on the Rocky Mountain and mid-continent regions of the United States. Currently, Wind River Energy has a five-project portfolio located in the U.S. Rocky Mountains and mid-continent regions. The Company's shares trade on the TSX Venture Exchange. Wind River Energy is based in Vancouver, British Columbia and they have an office in Englewood, Colorado.
The Company has two gas projects in Wyoming and three oil projects located in Colorado/New Mexico, Kansas and Montana. In total, Wind River holds 67,745 gross acres of leased oil and gas properties. This gives the Company ownership of resources in the Bakken/Three Forks, Nisku, Niobrara, Greenhorn, Mississippian and other formations.
The Company's projects include the Day Butte Project. Wind River Energy has a 100 percent working interest in this 1,578-acre rich natural gas project in Wyoming. It has one existing well, the Federal #1-17 well. The Company also has their Phat City Project. It is located in Valley County of northeastern Montana, near the town of Glasgow. Wind River is the operator of the project and owns a 70.3125 percent working interest in the project. The project consists of 56,785 gross (45,742 net) acres.
In addition, Wind River Energy has their Milagro project. It is located in northern New Mexico and southern Colorado. As of Q4, 2011, Wind River leased 13,185 gross and 9,218 net acres of this territory. Furthermore, the Company has their Emerald Forest Project. It is located in SW Wyoming. It involves the redrilling of a well that made a very significant gas discovery at shallow depths (approximately 5,500 feet deep) while looking for a deeper oil accumulation. Wind River Energy has acquired 2,240 acres on this prospect and is acquiring additional acreage.
Earlier this month, Wind River Energy announced that they suspended drilling activities on their second Nisku targeted well and will plug the Nelson 9-14 well pending further study. The Nelson 9-14 well was drilled to the Nisku formation, which was determined to have non-commercial properties. Oil shows were logged in the upper Nisku but the thickness and porosity were determined to be inadequate for commercial production.
Sidewall cores were retrieved in the Nisku, Bakken/Three Forks, Charles 'C', and Frontier formations. Strong gas shows were recorded in the Frontier and Niobrara formations. Strong oil shows were recorded in the Bakken/Three Forks and the Charles 'C' formation, which have produced significant amounts of oil from nearby fields.
Wind River Energy Corp. (WVR.V), closed on Wednesday at $0.05, even with yesterday’s close, on 55,900 volume. The 52-week low/high is $0.05/$0.40.
Attitude Drinks, Inc. (ATTD)
SmallCapVoice, OTCPicks, HotShotStocks, FeedBlitz, Stock Analyzer, Investor News Source, and Bull Warrior Stocks reported earlier on Attitude Drinks, Inc. (ATTD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Attitude Drinks, Inc. is a beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. The Company focuses on delivering experiential, functional and healthful beverages. Attitude Drinks has developed their Phase III® Recovery beverage. The Company has their corporate headquarters in Palm Beach Gardens, Florida. Attitude Drinks' shares trade on the OTC Bulletin Board.
Phase III® Recovery sells in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. The product is a reduced sugar, low fat, real flavored milk. It features 29 percent less sugar and more than 2 times the protein of regular chocolate milk.
Attitude Drinks filtered out the lactose and much of the sugar naturally found in low fat milk. Phase III™ has no protein added. The concentrated mineral and nutrient rich milk provides 35 grams of protein and the taste and mouth feel of low fat chocolate milk. This process enables strategically balanced protein and carbohydrate levels and fortification with a strong list of nutrients and electrolytes. Phase III® is packaged in 14.5-ounce re-sealable, environmentally "green" bottles.
Recently, Attitude Drinks announced increased activity in sales and marketing efforts through April 2012, throughout the Boston Metro area. The Company announced a substantial increase in sales with not only Tedeschi Food Shops but also elsewhere within the Great State/Blue Coast Beverages Distribution System.
More specifically, sales through Great State Distribution and Tedeschi Food Shops nearly doubled when comparing April 2011 to April 2012. Great State Beverage in New Hampshire and their wholly owned subsidiary Blue Coast Beverage in Mattapoisett, Massachusetts provide strong distribution with a reputation for building premier brands throughout New England. Attitude Drinks kicked off the Phase III® spring and summer sampling initiative with the Boston Marathon.
Attitude Drinks, Inc. (ATTD), closed on Wednesday at $0.001, down 8.33%, on 24,428,341 volume with 44 trades. The average volume for the last 60 days is 9,975,770. The 52-week low/high is $0.0001/$0.01.
Net Medical Xpress Solutions (NMXC)
Hawk Associates reported recently on Net Medical Xpress Solutions (NMXC), Stock Guru did previously, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
New Mexico Software, Inc., d/b/a Net Medical Xpress Solutions is a medical services company that lists on the OTC Bulletin Board. The Company provides clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. They also develop FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments. Net Medical Xpress Solutions has their headquarters in Albuquerque, New Mexico.
Net Medical Xpress is a trade name of New Mexico Software. They provide XR-EXpress PACs (Picture Archiving and Communication Systems) hardware and software to hospitals and other medical facilities. They provide a FDA 510k cleared PACS available for installation at a medical facility or it can undergo integration as a "web service" while data integrity, PHI, security, and HIPAA compliance are always maintained.
The Company has three operational units: Net Medical Xpress Solutions™, Net Medical Xpress Services™ and Net Medical Xpress Specialists. Concerning Net Medical Xpress Services™, their 40 American Board-certified radiologists and 15 board certified cardiologists diagnose plain film, ultra sounds, CT, MRI, Echo, EKG, and Fluoroscopy's 24/7/365. Their Operations team manages the workload for more than 15,600 facilities on their system.
Concerning Net Medical Xpress Specialists, their clinical unit provides telemedicine to remote hospitals with specialists credentialed for services. These services include neurology as well as stroke services, cardiology, infectious diseases, renal exams, retinal, psychology, and dermatology.
Last month, New Mexico Software, Inc., d/b/a Net Medical Xpress announced that Miners' Colfax Medical Center in Raton, New Mexico has enrolled in the clinical telemedicine services provided via their Net Medical Xpress Specialist Program. Net Medical Xpress' Specialist Program provides medical specialists to rural medical facilities on an as needed basis. This eliminates the need for, and cost of, full time staffing in infrequently needed specialties. The web-based program enables specialists located in population centers with the ability to make real-time assessments of patients at rural medical facilities through a secure and HIPAA compliant video examination.
Net Medical Xpress Solutions (NMXC), closed on Wednesday at $0.04, even with yesterday’s close, on 20,000 volume with 2 trades. The average volume for the last 60 days is 40,498. The 52-week low/high is $0.01/$0.04.
CD International Enterprises, Inc. (CDII)
Wall Street Resources reported yesterday on CD International Enterprises, Inc. (CDII), Greenbackers, Investor Ideas did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CD International Enterprises, Inc. produces, sources, and distributes industrial commodities in China and the Americas and provides business and financial corporate consulting services. The Company's unique infrastructure provides a platform to expand business opportunities around the world while effectively and efficiently accessing the U.S. capital markets. CD International Enterprises has their headquarters in Deerfield Beach, Florida with corporate offices in Shanghai, China.
Currently, the Company operates in two primary business segments: Magnesium and Basic Materials. Their third business segment is Consulting Services. They provide consulting services mainly to Chinese entities seeking to compete in a global economy.
CD International Enterprises currently operates six magnesium facilities in China within their Magnesium segment. These produce and/or distribute magnesium products including pure magnesium ingots, magnesium powders, granules and alloys. The current annual production capacity within their Magnesium segment is approximately 80,000 metric tons of pure magnesium ingots and 10,000 metric tons of magnesium powder. They have consolidated their magnesium operations under their International Magnesium Group (IMG) subsidiary.
Concerning their Basic Materials segment, the Company believes demand will continue to be strong for basic materials. These include industrial chemicals, basic metals and minerals, and other basic resources. As pertains to their consulting services, CD International Enterprises' services include strategic planning, business development, investment and financing assistance, M&A planning and analysis, modeling and valuation analysis, financial management, SEC report filings and management, SOX 404 compliance, and investor and public relations services.
Recently, the Company announced financial results for the second quarter of fiscal 2012 ended March 31, 2012. For the second quarter of fiscal 2012, total revenues were $41.9 million with net income attributable to common stockholders of $2.0 million. This is in comparison to revenues of $42.3 million, with a net loss attributable to common stockholders of ($14,000) recorded in the second quarter of fiscal 2011. Their gross profit margin in the second quarter of fiscal 2012 increased to 15.6 percent compared to 7.6 percent in the comparable period in fiscal 2011.
CD International Enterprises, Inc. (CDII), closed on Wednesday at $0.32, down 1.51%, on 73,592 volume with 78 trades. The average volume for the last 60 days is 176,724. The 52-week low/high is $0.25/$1.17.
Ecosphere Technologies, Inc. (ESPH)
Wall Street Resources reported yesterday on Ecosphere Technologies, Inc. (ESPH), SmallCapVoice, FeedBlitz did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCBB, Ecosphere Technologies, Inc. is a diversified water engineering, technology licensing and environmental services company. They design, develop, and manufacture wastewater treatment technologies for an assortment of industrial markets. The Company provides environmental services and technology solutions for large-scale, sustainable applications across industries, nations and ecosystems. Ecosphere Technologies has their headquarters in Stuart, Florida.
Currently, the Company is driving clean water innovation with their patented Ozonix advanced oxidation technologies and mobile, low-maintenance water treatment systems. Their Ozonix technology is a high-volume, advanced oxidation process designed to recycle water while reducing liquid chemicals used during water treatment applications.
Ozonix™ is a Patented Advanced Oxidation Technology that uses Ozone, Hydrodynamic Cavitation, Acoustic Cavitation, and Electro-Oxidation to oxidize and destroy microorganisms from contaminated water. With Ozonix™ there is no need for chemical biocides. A single Ozonix™ advanced oxidation system can process up to 3,300 gallons per minute - treating water to a level that is suitable for re-use. Ozonix™ products are mobile, self-contained and fully transportable.
The Ecosphere Ozonix® Technology offers customers a chemical-free alternative to high-volume water recycling for a diverse range of applications. These range from the oil & gas industry and mining to agriculture, municipal wastewater treatment, and renewable energy. Ecosphere Technologies has enabled oil and gas customers to recycle and reuse more than 1.8 billion gallons of water on approximately 530 oil and natural gas wells in major shale plays across the nation since 2008. The Company's Ozonix™ technology is the only advanced oxidation process proven to provide high-volume, chemical-free water treatment and recycling services at the frac site for oil & gas operators.
This month, Ecosphere Technologies announced that they appointed Ocean Tomo as their global licensing advisor. Ocean Tomo is an industry leader in intellectual property valuation, research, investment, risk management and transactions. They will work closely with Ecosphere to assist the Company in developing and implementing a global licensing program for their patented Ozonix technology and related products.
Ecosphere Technologies, Inc. (ESPH), closed on Wednesday at $0.47, down 4.08%, on 28,002 volume with 6 trades. The average volume for the last 60 days is 134,335. The 52-week low/high is $0.35/$0.77.
Lightlake Therapeutics, Inc. (LLTP)
SmallCapVoice, Bull Warrior Stocks, Market FN, The Best Newsletters, AnotherWinningTrade, SmallCapVoice, and Forbes reported earlier on Lightlake Therapeutics, Inc. (LLTP). Stockoutlaws, OTCPicks, Hidden Values Alert, Stealth Stocks, Wyatt Investment Research, and PennyTrader Publisher did as well, and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Lightlake Therapeutics, Inc. is an early stage biopharmaceutical company with corporate headquarters in London, England. The Company is using their expertise in opioid antagonists to develop innovative treatments for common addictions and related disorders. At present, they are focusing on developing a treatment for overweight and obese patients with Binge Eating Disorder, and a treatment for patients with Bulimia Nervosa. Lightlake Therapeutics' shares trade on the OTC Bulletin Board.
In April 2012, the Company completed a Phase II clinical trial in Helsinki, Finland to investigate the use of the opioid antagonist naloxone delivered intra-nasally as a treatment for Binge Eating Disorder. The science Lightlake Therapeutics is using to develop a treatment for Binge Eating Disorder is derived from the "Sinclair Method," for the treatment of alcohol dependency, which was developed by the Company's Chief Science Officer, Dr. David Sinclair.
For this year, Lightlake Therapeutics anticipates launching Phase II trials to investigate the application of their technology as a treatment for Bulimia Nervosa. The Company is seeking funding to facilitate these trials launches. They have arranged with Kings College London, UK, to conduct these trials at the institution. Kings College has an internationally renowned eating disorder unit.
Professor Janet Treasure, head of the Eating Disorders Unit at the South London and Maudsley NHS Trust and author of several well-regarded books on eating disorders, and Professor Ulrike Schmidt, a consultant psychiatrist for the Eating Disorders Service and a fellow of the Academy for Eating Disorders, will serve as guides for these Phase II trials.
In early May, Lightlake Therapeutics announced very encouraging preliminary results in the Phase II clinical trial of the Company's opioid antagonist nasal spray treatment for patients with Binge Eating Disorder (BED). The Company's randomized, double blind, placebo-controlled, six-month Phase II clinical trial enrolling 127 subjects in Helsinki for the treatment of binge eating disorder (BED) with intranasal naloxone completed successfully. There were no serious adverse events and 81 percent of patients completed the entire six months with no statistically significant difference in dropout rates between the placebo and the treatment groups.
Lightlake Therapeutics, Inc. (LLTP), closed on Wednesday at $0.09, up 10.005, on 10,000 volume with 2 trades. The average volume for the last 60 days is 225,155. The 52-week low/high is $0.04/$0.74.
Open Range Energy Corp. (ONR.TO)
Today we are reporting on Open Range Energy Corp. (ONR.TO), here at the QualityStocks Daily Newsletter.
Open Range Energy Corp. is an energy company based in Calgary, Alberta. The Company has focused operations in the Deep Basin of west central Alberta and a goal to achieve production of 10,000 boe per day by year-end 2012. Open Range is developing horizontal opportunities in multiple target zones at three Deep Basin properties. The Company's shares list on the Toronto Stock Exchange.
Open Range Energy has an exploration-based approach focusing on high quality, multi-zone, repeatable targets holding large resource-in-place and long-life reserves potential in the Deep Basin of west central Alberta. The Company is pursuing horizontal development of multiple zones. These include the Wilrich, Notikewin, Cardium, Bluesky, Montney and Glauconitic, plus other emerging opportunities. Open Range is working to maintain a low-risk vertical and horizontal production base at the core Ansell/Sundance asset to provide cash flow for growth-oriented activities at Ansell/Sundance and elsewhere.
At the Company's core Ansell/Sundance Deep Basin property, Open Range is taking advantage of the strong drilling success of their predecessor company. As of year-end 2011, Open Range was operating 45 gross producing vertical wells and 15 gross producing horizontal wells, with a future drilling inventory of at least 150 vertical locations and 100 horizontal locations.
This month, Cequence Energy Ltd. and Open Range Energy announced that they entered into an amended and restated arrangement agreement. This is to amend certain terms of the previously announced arrangement agreement between Open Range and Cequence, whereby Cequence agreed to acquire all of the common shares of Open Range pursuant to a plan of arrangement under the Business Corporations Act (Alberta).
Pursuant to the previously announced terms of the Arrangement Agreement, Open Range shareholders were to receive 1.065 common shares of Cequence for each Open Range Share held. Under the terms of the Amended and Restated Arrangement Agreement, Cequence will increase the consideration payable to holders of Open Range Shares by increasing the Exchange Ratio to 1.1 Cequence Shares for each Open Range Share.
Open Range Energy Corp. (ONR.TO), closed on Wednesday at $1.02, up 4.08%, on 1,997,870 volume. The 52-week low/high is $0.93/$11.94.
Peregrine Pharmaceuticals, Inc. (PPHM)
Buzz Stocks reported recently on Peregrine Pharmaceuticals, Inc. (PPHM), StreetInsider, Greenbackers did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Peregrine Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The Company's clinical pipeline includes bavituximab, a first-in-class monoclonal antibody with demonstrated broad-spectrum potential in cancer and viral diseases, and Cotara®, their novel brain cancer therapy. Both bavituximab and Cotara are currently in Phase II clinical development. Peregrine Pharmaceuticals has their corporate headquarters in Tustin, California.
In addition, the Company has in-house cGMP manufacturing capabilities through their wholly owned subsidiary Avid Bioservices, Inc. Avid provides development and biomanufacturing services for both Peregrine and outside customers.
For oncology indications, Peregrine's lead phosphatidylserine (PS)-targeting candidate bavituximab in combination with chemotherapy has demonstrated promising signs of anti-tumor activity in patients with non-small cell lung cancer (NSCLC) and advanced breast cancer. Based on these encouraging results, the Company is currently conducting three randomized Phase II trials in different oncology indications. For viral infection indications, bavituximab has undergone evaluation in combination with ribavirin in a randomized Phase II trial in 66 treatment naive patients with genotype-1 hepatitis C virus (HCV) infection. The compound is also undergoing assessment in four investigator-sponsored trials in additional oncology indications.
Cotara is the Company's lead Tumor Necrosis Therapy (TNT) agent. It is currently undergoing evaluation in a Phase II clinical trial in glioblastoma multiform (GBM) patients at first relapse. Cotara targets necrotic cells at the core of solid tumors. It transports and binds radioactive iodine to the center of the tumor, allowing the radiation to destroy the tumor from the inside out.
This week, Peregrine Pharmaceuticals announced the completion of enrollment and randomization of 70 patients in a Phase II trial evaluating bavituximab in combination with gemcitabine versus gemcitabine alone in patients with previously untreated stage IV pancreatic cancer.
Mr. Steven W. King, President and Chief Executive Officer of Peregrine, said, "Completion of patient enrollment in this trial represents another important milestone for our bavituximab oncology program. With standard chemotherapeutic treatment yielding only minor improvements in patient survival and newer combination regimens demonstrating significant toxicities, there is an urgent need for more effective treatment options."
Peregrine Pharmaceuticals, Inc. (PPHM), closed on Wednesday at $0.51, up 2.98%, on 286,422 volume with 608 trades. The average volume for the last 60 days is 807,321. The 52-week low/high is $0.39/$2.27.
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0070, even for the day. The stock’s average daily volume over the past 60 days is 82,651, and its 52-week low/high is $0.001/$0.018.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Completes Acquisition of Tarsin Inc.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.55, off by 3.13%, on 7,020 volume with 8 trades. The stock’s average daily volume over the past 60 days is 5,686, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. issued a report today covering the company’s extant progress, as well as near-term expansion plans to push out into broader international markets, bolstered by the strong cloud-based Enterprise Content Management presence established through wholly-owned subsidiary, Intellinetics, Inc. domestically. GlobalWise is now embarking on a more comprehensive Channel partner strategy.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Reports on International Expansion Initiatives
GlobalWise to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
GlobalWise Signs Channel Sales Partnership With Sycle.net
USA Recycling Industries, Inc. (USRI)
The QualityStocks Daily Newsletter would like to spotlight USA Recycling Industries, Inc. (USRI). Today, USA Recycling Industries, Inc. closed trading at $0.09, even with yesterday's close, on 2,943 volume with 1 trade. The stock’s average daily volume over the past 60 days is 16,855, and its 52-week low/high is $0.03/$0.14.
USA Recycling Industries, Inc. (USRI) is a mid-market recyclable waste collection & disposal service, providing specialty recycling programs to commercial & industrial customers throughout North America. Operating through multiple company-owned & partnership recycling centers, the company primarily targets growth opportunities in the $75 billion global scrap metals market.
USA Recycling has operated since its inception in 2000, and its largest operating subsidiary, Scrap USA, since 2007 has been focused on and successful in servicing the automotive service center industry. It currently provides specialty recycling programs to more than 5,000 automotive service center locations operated by some of the most recognizable names in that retail category.
With a well-established national footprint, the company is now integrating other ancillary services such as the collection & disposal of other recyclable waste streams. USA Recycling has also opened the door to franchising opportunities and recently signed a proprietary revenue sharing agreement with Recycling Franchisors, Inc. Other initiatives to drive growth and boost prominence include the launch of a new website and relocation of executive offices.
USA Recycling has successfully contracted automotive waste-generators for collection & disposal services, selling the processed recyclable materials to end-user-consumers through the company's trading operations with offices in North America, India, and the United Arab Emirates. The company's primary aim is to maximize shareholder value while providing the highest level of quality waste collection & disposal services to its customers, ensuring its collected debris remain free of any U.S. landfills. Disclaimer
USA Recycling Industries, Inc. Company Blog
USA Recycling Industries, Inc. News:
USA Recycling Industries to Provide Scrap Metal Collection Services to ThyssenKrupp Elevator Americas
USA Recycling Industries Enters Oil Filter Collection and Disposal Services Agreement With Redwood Recycling
USA Recycling Industries Signs Letter of Intent to Expand Used Oil Filter Recycling Operations
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.36, off by 5.26%, on 32,866 volume with 14 trades. The stock’s average daily volume over the past 60 days is 196,865, and its 52-week low/high is $0.21/$1.15.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology
International Stem Cell Corporation Announces Marketing Plans for Its Wholly Owned Subsidiary Lifeline Skin Care
International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights
Consorteum, Inc., a wholly owned subsidiary of Consorteum Holdings, Inc., a provider of technology solutions to companies and organizations looking to expand their methods of processing payment transactions, just announced its intent to join forces with Marksal Communications, Inc., one of Canada’s leading providers of global communications solutions, in order to meet the growing demand for next-generation telecommunication and financial transaction services across the North American and International markets.
By combining the technical innovation of Consorteum’s payment processing solutions with the significant capability of Marksal to provide secure communications to remote regions, the anticipated joint venture would provide customers with new capabilities to deliver payment and banking services in areas that traditionally have been underserved. Together with Consorteum’s new focus on mobile application delivery of secure financial transactions, the new joint venture will allow the delivery of next-generation telecommunication and financial services anywhere in the world.
“This new joint venture will allow both companies to leverage their core competencies to better serve their customers,” commented Craig Fielding, CEO of Consorteum, Inc. “This alliance with Marksal Communications provides the ability to deliver secure financial transactions to areas traditionally isolated, and it opens up a tremendous market for new services while facilitating economic growth.”
“This joint venture with Consorteum is very exciting and will provide a unique solution for the delivery of secure financial transactions,” added William MacDonald, CEO of Marksal Communications, Inc. “Marksal is very committed to delivering their expertise and solutions, anywhere in the world, in this new joint venture.”
Under the proposed joint venture, Consorteum will contribute its proven payment solutions and Marksal will provide the communications infrastructure necessary to link remote areas into secure telecommunication and financial services, thus creating an overlay of new, sophisticated financial networks. According to today’s release, Consorteum Holdings will own 51 percent of the joint venture, and Marksal will own 49 percent of the joint venture.
For more information about the company, visit www.consorteum.com
GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today provided investors with an update on the company’s progress to date and near term intentions to expand into international markets.
For nearly two decades, Intellinetics has focused primarily on domestic United States markets, selling ECM software services through a traditional, direct sales force. This strategy has served Intellinetics well, but the original father-son management team of Matthew and Michael Chretien saw the opportunity to expand the business by hiring international executive William J. “BJ” Santiago. Recruited from Lexmark, Mr. Santiago was brought on to lead the new cloud-based ECM software enterprise and expand the company’s distribution through a one-to-many strategy utilizing Channel Partners who already have a tested and proven model to sell hardware or software related services.
Eight new Channel Partners have been brought on in just the past seven months to continue software sales expansion in the United States, as well as pursue new opportunities internationally. This Channel Partner strategy has shown it is possible to distribute ECM software services in every industry. By utilizing distribution partners who already have an extensive sales force and customer base, GlobalWise is able to focus on being a software company while the Partners emphasize on client sales and on-going support.
Recently, the company announced an agreement with SOIN Integrales (www.soin.co.cr), headquartered in Costa Rica, who dominates the Latin America market selling high-end ERP solutions from companies like Oracle, SAP, and Sybase. Historically, SOIN did not have an ECM (Enterprise Content Management) practice within their software product offerings. However, similar to the US, Latin America is rapidly adopting digital management of document and records for compliance and privacy regulation and historically did not have a cost effective ECM solution.
Today, through the Intellinetics On-demand Solution Store™ templates, SOIN can capitalize on this untapped small to medium sized client base through an exclusive agreement with Intellinetics. Over the past several months, the companies have worked closely together to translate the Intellivue™ software and related product collateral into Spanish and are currently marketing the software services. The initial Intellivue™ solution and product launch has begun in Mexico, Costa Rica, Panama, El Salvador, and Nicaragua.
Additionally, the Intellinetics agreement with MWAi will begin the company’s first foray into English speaking countries in Europe, with expansion expected to begin in the third quarter of 2012. Since Intellinetics has invested heavily in their template based best practice ECM solutions for a variety of industries, the current software will need very little upgrading aside from potential cultural differences. Perhaps even more exciting for Intellinetics and MWAi is the on-going efforts to convert the Intellivue™ cloud-based ECM software into a double-byte character set (DBCS), a software language typical for Japanese, Korean and Chinese translations. By employing DBCS, the Intellinetics software suite will be ready for clients in the Asia-Pacific Rim later this year.
“GlobalWise is positioning itself for record-breaking growth for the balance of 2012 and 2013,” proclaimed William. J. “BJ” Santiago, CEO of GlobalWise. “We have and will continue to recruit many strategic Partners to help us access more industries and markets. I expect we will have additional announcements in the near future regarding further domestic and international growth.”
“The great news with a cloud-based service delivery model, now available in both English and Spanish and soon for the Asian market, is the multitudes of ways to get our software into the hands of clients,” added Mr. Santiago. “Whether it’s integrating the ECM capabilities into an existing CRM or ERP system, implementation with multi-function printers or sold as a stand-alone solution, our software is dynamic enough to sit alongside almost any other architecture. The cloud delivery model provides a lower cost delivery approach without major capital expenditures that is perfect in the emerging ECM markets that previously did not have a cost effective solution.”
For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com
Meru Networks, a leader in virtualized 802.11 enterprise wireless networks, announced that it has made its Identity Manager product available. Identity Manager is the industry’s original integrated Bring-Your-Own-Device (BYOD) provisioning and guest access solution with the capability of using a Property Management System (PMS).
Identity Manager is able to streamline secure guest access and BYOD provisioning for nearly every operating and network in use today. This simplification drastically decreases IT workload while delivering an easy on-boarding experience for users. The integrated software platform, deployed at over 2,500 customers, is comprised of two modules, the first of which is known as Smart Connect. Smart Connect enables automated BYOD client provisioning. The second module is the Guest Connect network access solution, which integrates perfectly with property management systems and payment gateways. This integration simplifies administrative tasks and billing for guest Internet access, allowing customers to effortlessly accept credit card payments from their guests.
Using Meru Identity Manager, enterprises can easily and effectively serve the thousands of Wi-Fi devices and applications that are used within their wireless environment, delivering smooth network access in accordance with corporate IT policies.
• Meru Identity Manager now has integrated Property Management System (PMS) functionality that enables businesses, including hotels and convention centers, to automate service charges for Wi-Fi or Internet access services, and automatically post service charges to over 80 different popular industry billing entities.
• Meru Identity Manager’s vendor agnostic architecture enables it to provision services over wired or wireless networks.
• Clients supported by Meru Identity Manager include Apple iOS (iPhone and iPad), Apple Mac OS X, Google Android, Linux and Microsoft Windows (XP, Vista and 7).
• Meru Identity Manager is designed to reduce IT workload by automating the device and user on-boarding process without jeopardizing network security.
• Enterprise-strength authentication and encryption protect the network and sensitive data, while role-based and policy-based provisioning gives IT departments control over whom and what devices get access.
• Identity Manager is designed to deliver the industry’s most complete and comprehensive activity monitoring/reporting for guest users and devices, which is critical for ensuring appropriate use to protect company networks.
• Identity Manager technology is currently deployed in over 2,500 customer accounts worldwide, including many Fortune 500 companies, higher education institutions, large hotel chains, major league sports stadiums, and global convention centers.
• Identity Manager is available in a VMware ready format for customers who have chosen a virtualized application platform strategy.
For further information, please visit www.merunetworks.com
NCI announced yesterday that it has been awarded a competitive task order valued at $6.4 million to provide modeling, simulation, and network operations security center (NOSC) engineering support for the United States Army’s Signal Center of Excellence, Capabilities Development Integration Directorate, Experimentation Division located at Fort Gordon, GA. The period of performance begins July 1st and includes a base year and two option years.
According to the task order, NCI will develop modeling and simulation tools, information-dissemination management tools, data, products, analysis methods, and deliverables for the Government to use in support of the Army’s current and future communications experimentation and analytical requirements.
The task also includes maintaining the NOSC for the Battle Lab Collaborative Simulation Environment (BLCSE), which supports all the Training and Doctrine Command’s distributed experimentation events in a classified environment. BLCSE support includes day-to-day operations for approximately 24 distributed sites in the areas of system administration, collaboration tools, network design, network and data implementation, and information assurance requirements.
Brian J. Clark, NCI’s president, remarked, “NCI is very pleased to broaden our relationship with the Army through services we will provide to the U.S. Army’s Signal Center of Excellence at Fort Gordon. This award not only represents new business for NCI, but also a strategic entrée into a key new location. We look forward to supporting the mission of the Capabilities Development Integration Directorate, Experimentation Division.”
Today's Top 3
The QualityStocks Public Company Sponsor News